Klotho supplementation reduces BP, renal angiotensinogen, Ang II, and HIF-1, mammalian target of rapamycin (mTOR), Akt, and medullary fibrosis in adult SHR-SP with nephrosclerosis [239]. This evidence concerns the gene MTOR and nephrosclerosis.